RemedyBio’s CSO Dr. Paul Leonard is leading an independent validation study of commercially available COVID-19 serological tests, with the aim of recommending the best in class tests for nationwide seroprevalence studies in Ireland. This project is funded by DCU’s COVID-19 Research and Innovation Hub.
Recommended For You
RemedyBio announces a new collaborative research project to advance cancer therapies
Remedy BiologicsJune 6, 2022